Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Amgen
Biotech
Amgen dances with Disco in $618M cancer target pact
Amgen has commissioned Disco to develop cancer therapies focused on a target the German biotech has already identified.
James Waldron
Jan 7, 2026 10:15am
Amgen weaves in UK biotech with up to $840M acquisition
Jan 6, 2026 10:35am
Zenas stock sinks on autoimmune readout despite hitting endpoint
Jan 5, 2026 9:30am
Fierce Pharma
Amgen obesity marketing head Boulton departs to lead Prolynx
Dec 11, 2025 10:40am
Analyst deems Janux's stock spiral an 'overreaction'
Dec 2, 2025 11:14am
Merck's PCSK9 drug mounts injectable-like cholesterol reductions
Nov 10, 2025 10:59am
